Skip to main content
. 2022 Nov 23;32(5):481–489. doi: 10.1097/BPB.0000000000001041

Table 3.

Stratification analysis based on different diagnostic cutoff of procalcitonin

Cutoff of procalcitonin (ng/ml) Sensitivity Specificity Positive likelihood ratio Negative likelihood ratio Diagnostic odds ratio Area under curve
≥0.1 0.72 (0.65–0.79) 0.90 (0.87–0.93) 3.87 (2.53–5.90) 0.39 (0.22–0.70) 13.13 (6.46–26.66) 0.88
≥0.2 0.70 (0.62–0.77) 0.91 (0.88–0.93) 4.32 (2.39–7.78) 0.43 (0.25–0.74) 10.50 (5.87–18.80) 0.83
≥0.3 0.68 (0.60–0.76) 0.91 (0.88–0.94) 4.67 (2.06–10.62) 0.48 (0.29–0.79) 9.44 (5.24–17.03) 0.82
≥0.4 0.49 (0.33–0.65) 0.96 (0.94–0.98) 7.83 (3.20–19.14) 0.58 (0.37–0.91) 16.05 (4.97–51.86) 0.93
≥0.5 0.49 (0.33–0.65) 0.96 (0.94–0.98) 7.83 (3.20–19.14) 0.58 (0.37–0.91) 16.05 (4.97–51.86) 0.93